Common shares of Caribou Biosciences, Inc., trading on the NASDAQ exchange under the ticker symbol CRBU, maintain a market valuation hovering around $1.76 per share. Equity valuations shift dynamically throughout active trading sessions based on daily market liquidity, institutional order matching, genomic editing research updates, and periodic corporate earnings disclosures. Market participants tracking the security should consult live financial market data platforms or brokerage accounts right before executing trades.